IP Library › Assignment 030831/0075
Patent Assignment
Reel/Frame 030831/0075

Change of Name

Recorded: 2013-07-18 Pages: 6
Assignor
GTC BIOTHERAPEUTICS, INC.
Executed: 2013-03-21
Assignee
REVO BIOLOGICS, INC.
175 CROSSING BOULEVARD, FRAMINGHAM, MASSACHUSETTS, 01702
Covered Properties (11)
Transgenic Production of Antibodies in Milk
Patent: 5,827,690 →
Application: 08/170,579 →
Process for the Sterile Filtration of Milk
Patent: 5,576,040 →
Application: 08/282,256 →
Transgenically Produced Antithrombin Iii
Patent: 5,843,705 →
Application: 08/391,743 →
Transgenic Production of Antibodies in Milk
Patent: 5,849,992 →
Application: 08/410,887 →
Purification of Biologically Active Peptides from Milk
Patent: 6,268,487 →
Application: 08/648,235 →
Transgenically Produced Non-Secreted Proteins
Patent: 6,528,699 →
Application: 09/028,551 →
Transgenically Produced Antithrombin Iii
Patent: 6,441,145 →
Application: 09/143,155 →
Treatments Using Transgenic Goat Produced Antithrombin Iii
Patent: 7,019,193 →
Application: 10/188,658 →
Publication: US 2003/0096974
Transgenically Produced Antithrombin Iii
Patent: 7,928,064 →
Application: 11/284,585 →
Publication: US 2008/0176786
Clarification of Transgenic Milk Using Depth Filtration
Patent: 7,531,632 →
Application: 11/355,557 →
Publication: US 2007/0192878
A non-human transgenic mammal expressing a human FcRn on its mammary gland cells and expressing a transgenic protein-human Fc-domain fusion
Patent: 8,173,860 →
Application: 11/788,775 →
Publication: US 2008/0063780
Related Assignments (19)
Other recorded transfers of the patents in this record — the chain of ownership.
Corrective Assignment to Correct the Assignment Recordation Previously Recorded on Reel 011497 Frame 0572. Assignor(S) Hereby Confirms the Execution Date Should Be Listed as 12/07/2000. Jan 18, 2013
From: MOLLER, WOLFGANG
To: GENZYME TRANSGENICS CORPORATION
Reel/Frame 029660/0539 →
Corrective Assignment to Correct the Application Number 08232256 to 08282256 Previously Recorded on Reel 030831, Frame 0075. Assignors Hereby Confirms the Application Number. Jul 31, 2013
From: GTC BIOTHERAPEUTICS, INC.
To: REVO BIOLOGICS, INC.
Reel/Frame 031012/0924 →
Corrective Assignment to Correct the Application Number 08232256, to 08282256, Previously Recorded on Reel 030831, Frame 0075. Aug 13, 2013
From: GTC BIOTHERAPEUTICS, INC.
To: REVO BIOLOGICS, INC.
Reel/Frame 031161/0462 →
Change of Name Aug 15, 2013
From: GTC BIOTHERAPEUTICS, INC.
To: REVO BIOLOGICS, INC.
Reel/Frame 031030/0152 →
Corrective Assignment to Correct the Assignment Recordation Previously Recoded on Reel 030831, Frame 0075. Assignors Hereby Confirms the Following Application Number Was Incorrectly Inputted as 08232256 and Confirms the Change of Name. Aug 15, 2013
From: GTC BIOTHERAPEUTICS, INC.
To: REVO BIOLOGICS, INC.
Reel/Frame 031058/0292 →
Release of Security Interest Mar 11, 2014
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: GTC BIOTHERAPEUTICS, INC.
Reel/Frame 032424/0230 →
Release of Security Interest Mar 14, 2014
From: LFB BIOTECHNOLOGIES S.A.S.U.
To: GTC BIOTHERAPEUTICS, INC.
Reel/Frame 032448/0045 →
Assignment of Assignor's Interest May 8, 2014
From: REVO BIOLOGICS, INC.
To: LFB USA, INC.
Reel/Frame 032845/0952 →
Assignment of Assignor's Interest May 8, 2014
From: REVO BIOLOGICS, INC.
To: LFB USA, INC.
Reel/Frame 032845/0955 →
Assignment of Assignor's Interest May 8, 2014
From: REVO BIOLOGICS, INC.
To: LFB USA, INC.
Reel/Frame 032846/0084 →
Assignment of Assignor's Interest May 8, 2014
From: REVO BIOLOGICS, INC.
To: LFB USA, INC.
Reel/Frame 032846/0091 →
Assignment of Assignor's Interest May 8, 2014
From: REVO BIOLOGICS, INC.
To: LFB USA, INC.
Reel/Frame 032846/0099 →
Assignment of Assignor's Interest May 8, 2014
From: REVO BIOLOGICS, INC.
To: LFB USA, INC.
Reel/Frame 032846/0217 →
Assignment of Assignor's Interest May 16, 2014
From: REVO BIOLOGICS, INC.
To: LFB USA, INC.
Reel/Frame 032916/0675 →
Assignment of Assignor's Interest May 16, 2014
From: MEADE, HARRY; POLLOCK, DANIEL; DITULLIO, PAUL
To: GENZYME CORPORATION
Reel/Frame 032916/0638 →
Assignment of Assignor's Interest May 16, 2014
From: GENZYME CORPORATION
To: GENZYME TRANSGENICS CORPORATION
Reel/Frame 032916/0672 →
Security Interest Dec 7, 2016
From: PHARMING INTELLECTUAL PROPERTY B.V.
To: SILICON VALLEY BANK
Reel/Frame 040839/0865 →
Amended and Restated Intellectual Property Security Agreement May 16, 2017
From: PHARMING INTELLECTUAL PROPERTY B.V.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 042481/0139 →
Release of Security Interest Jan 28, 2020
From: ORBIMED ROYALTY OPPORTUNITIES II, LP
To: PHARMING GROUP N.V.; PHARMING TECHNOLOGIES B.V.; PHARMING INTELLECTUAL PROPERTY B.V.; BROEKMAN INSTITUUT B.V.
Reel/Frame 051722/0304 →